Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Clocortolone Pivalate
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 26, 2012
Lead Product(s) : Clocortolone Pivalate
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clocortolone Pivalate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : WAYCro
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 24, 2020
Lead Product(s) : Clocortolone Pivalate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : WAYCro
Deal Size : Inapplicable
Deal Type : Inapplicable